Cited by 34Organ Transplantation Techniques and OutcomesLiver physiology and pathologyTissue Engineering and Regenerative Medicine

Therapeutic Liver Reconstitution With Murine Cells Isolated Long After Death

Open access
Erker, Laura, Azuma, Hisaya, Lee, Andrew Y., Guo, Changsheng, Orloff, Susan, Eaton, Laura, Benedetti, Eric, Jensen, Bryan +3 more·2010·Gastroenterology

Abstract

Background & aims Due to the shortage of donor organs, many patients needing liver transplantation cannot receive one. For some liver diseases, hepatocyte transplantation could be a viable alternative, but donor cells currently are procured from the same sources as whole organs, and thus the supply is severely limited.Methods Here, we investigated the possibility of isolating viable hepatocytes for liver cell therapy from the plentiful source of morgue cadavers. To determine the utility of this approach, cells were isolated from the livers of non-heart-beating cadaveric mice long after death and transplanted into fumarylacetoacetate hydrolase-deficient mice, a model for the human metabolic liver disease hereditary tyrosinemia type I and a stringent in vivo model for hepatic cell transplantation.Results Surprisingly, complete and therapeutic liver repopulation could be achieved with hepatocytes derived up to 27 hours post mortem.Conclusions Competitive repopulation experiments showed that cadaveric liver cells had a repopulation capacity similar to freshly isolated hepatocytes. Importantly, viable hepatocytes also could be isolated from cadaveric primate liver (monkey and human) efficiently. These data provide evidence that non-heart-beating donors could be a suitable source of hepatocytes for much longer time periods than previously thought possible.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2010.05.082

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hepatocytes have a high replicative potential in vivo.

    “Hepatocytes have a high replicative potential in vivo3, 4, however hepatocyte isolation is technically demanding, requires cadaveric liver donation, and hepatocytes cannot be expanded effectively in vitro5.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [20]Lewandoski M Meyers EN Martin GR Analysis of Fgf8 gene function in vertebrate development Cold Spring Harb Symp Quant Biol 1997 62 159 68 9598348

Cited by

Sorted by citations

Authors
Erker, L., Azuma, H., Lee, A. Y., Guo, C., Orloff, S., Eaton, L., Benedetti, E., Jensen, B., Finegold, M., Willenbring, H., & Grompe, M.
Affiliations
  • Oregon Health & Science University (US)
  • University of California, San Francisco (US)
  • Texas Children's Hospital (US)
Corresponding author
Erker, Laura
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2010-09
Volume
139
Issue
3
Pages
1019-1029
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2148914475
Cited by
34
References
26
Citations by year
2024: 2 · 2023: 1 · 2021: 5 · 2020: 1 · 2019: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 5 · 2013: 6 · 2012: 4
FWCI
4.72
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK56338, R01DK051592, P30DK056338)
  • National Center for Research Resources (P51RR000163, K01RR000163, RR-00163.)
Topics
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
hepatocyte transplantation, liver cell therapy, donation after circulatory death, tyrosinemia type I, fumarylacetoacetate hydrolase deficiency, liver repopulation
MeSH terms
Animals, Cadaver, Cell Separation, Cell Survival, Cells, Cultured, Disease Models, Animal, Humans, Hydrolases, Liver, Liver Regeneration, Macaca mulatta, Proteins, Temperature, Time Factors, Tyrosine, Biomarkers, Mice, Knockout, Tyrosinemias, RNA, Untranslated, Hepatocytes, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review